Sprout Health Pricing 2026: What It Actually Costs

Sprout Health Pricing 2026: What It Actually Costs. Sprout Health pricing breakdown: compounded semaglutide from $149/mo, tirzepatide from $199/mo, plus brand-name Wegovy and Zepbound costs. Key Takeaways Compounded plans are the affordable tier: compounded semaglutide starts at $149/month and compounded tirzepatide at $199/month. Brand-name is a different budget entirely: Wegovy® starts at $1,799/month and Zepbound® at $1,999/month through the platform. Plans renew automatically: billing frequency and cancellation terms are shown before checkout, and Sprout claims no contracts and no surprise fees. The process is fully online: state-licensed US providers review your intake, and most prescriptions are sent to the pharmacy within two business days of completing the medical form. Compounded medications are not FDA-approved: Sprout Health states this directly, and it is the tradeoff behind the price gap versus brand-name. Short answer: Sprout Health's pricing splits into two very different lanes. The compounded lane — semaglutide starting at $149/month and tirzepatide at $199/month — sits in the middle of the compounded GLP-1 telehealth market. The brand-name lane — Wegovy® from $1,799/month and Zepbound® from $1,999/month — is cash-pay list-price territory for people who specifically want FDA-approved medication without going through insurance. This article breaks down every published number, what the subscription actually includes, and how the renewal terms work, so you know the full cost picture before you start the Sprout Health intake . Affiliate disclosure: some links in this article are affiliate links, and PeptideStack may earn a commission at no extra cost to you if you sign up through them. Sprout Health Pricing at a Glance These are the starting prices published on joinsprouthealth.com. As with every telehealth GLP-1 program, "starting at" means the entry dose tier — your actual monthly cost depends on what the reviewing provider prescribes and how your dose changes over time. Treatment Type Starting Price Compounded semaglutide Compounded GLP-1 From $149/month Compounded tirzepatide Compounded GLP-1 + GIP From $199/month Compounded GLP-1 / GIP-GLP-1 Compounded From $249 Wegovy® Brand-name (FDA-approved) From $1,799/month Zepbound® Brand-name (FDA-approved) From $1,999/month Provider-Guided NAD+ Compounded NAD+ therapy Not publicly listed One honest gap: Sprout Health offers a provider-guided compounded NAD+ program, but we did not capture a public price for it, so we are not going to invent one. If NAD+ is your main interest, the number will surface during intake. What the Subscription Includes Sprout Health is a 100% online telehealth program. The monthly price covers the clinical structure end to end: Medical review by state-licensed US providers: you complete an online medical form, and a licensed provider evaluates whether treatment is appropriate. There is no guarantee of a prescription — the provider makes that call. State-licensed US pharmacy fulfillment: prescriptions are filled by state-licensed US pharmacies, not overseas sources. Discreet home delivery: medication ships to your door. Fast turnaround: if prescribed, most prescriptions are sent to the pharmacy within two business days of completing the medical form. Dosing, titration, and medication selection are provider decisions made during and after review. If you have clinical questions — interactions, side effects, whether a GLP-1 fits your history — those belong with the licensed provider, not a pricing article. For general lifestyle questions people commonly ask on these medications, our guide to alcohol and tirzepatide covers one of the most frequent ones. How Billing and Renewal Work This is where subscription telehealth programs most often surprise people, so it is worth being precise about what Sprout Health publishes: Plans renew automatically. This is a subscription, not a one-time purchase. Billing frequency and cancellation terms are shown before checkout. Read that screen — it is the binding version of the terms, and it tells you exactly when the next charge lands and how to stop it. No contracts, no surprise fees. That is Sprout's own claim, and the pre-checkout disclosure is where you verify it applies to the plan you picked. The practical advice is the same we give for every auto-renewing program: screenshot the checkout terms, note your renewal date, and decide before that date whether you are continuing. GLP-1 treatment is typically a multi-month commitment, so the real cost question is not the first month — it is the price times the number of months you realistically stay on. Compounded vs Brand-Name: Why the Gap Is So Large The distance between $149/month compounded semaglutide and $1,799/month Wegovy® deserves a plain explanation. Wegovy® and Zepbound® are FDA-approved brand-name medications; their cash prices reflect manufacturer list pricing. Compounded semaglutide and tirzepatide are prepared by compounding pharmacies, and — as Sprout Health itself states — they are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Compounded drugs are neither brand-name nor generic; they occupy their own regulatory category. That is the entire tradeoff in one sentence: the compounded lane buys a roughly 90% lower monthly price in exchange for medication that has not been through FDA review. Sprout's structure routes both lanes through state-licensed US providers and state-licensed US pharmacies, which is the baseline you should demand from any platform in this market. But the FDA-approval distinction does not disappear at any price point, and a platform being upfront about it — as Sprout is — is a point in its favor. How Sprout Health Pricing Compares to the Market In the compounded GLP-1 telehealth field we track, entry pricing for semaglutide generally runs from around $99 to $299 per month, with tirzepatide $50–$100 above semaglutide on the same platform. Sprout Health's $149/$199 pairing lands squarely mid-market: not the cheapest listing available, and well below the premium programs that bundle heavy coaching. What you are paying for at this tier is the licensed-provider, US-pharmacy structure with fast two-business-day prescription turnaround and clearly disclosed renewal terms. The brand-name lane is harder to compare because most competitors simply do not list cash-pay Wegovy® or Zepbound® at all — if brand-name matters to you and you have insurance, checking your coverage first is almost always the cheaper route. For the wider landscape of who charges what, our comparison of GLP-1 telehealth providers lines up a dozen platforms side by side, and our peptide cost guide covers how prescription pricing relates to the rest of the peptide market. Who the Pricing Makes Sense For Sprout Health's compounded plans fit cash-pay patients who want a licensed, fully-online pathway at mid-market pricing, value the fast prescription turnaround, and want renewal terms disclosed upfront rather than discovered on a statement. The brand-name plans fit the narrower group that insists on FDA-approved medication, has no insurance coverage for it, and can absorb $1,799–$1,999 per month. Neither lane fits anyone whose insurance would cover a brand-name GLP-1 — run that check before paying cash anywhere. Frequently Asked Questions How much does Sprout Health cost per month? Compounded semaglutide starts at $149/month and compounded tirzepatide at $199/month. Brand-name Wegovy® starts at $1,799/month and Zepbound® at $1,999/month. A compounded GLP-1 / GIP-GLP-1 option starts at $249. Your actual price depends on the medication and dose your provider prescribes. Does Sprout Health require a subscription? Yes. Plans renew automatically, with billing frequency and cancellation terms shown before checkout. Sprout states there are no contracts and no surprise fees. How fast does Sprout Health send prescriptions? If a provider prescribes treatment, most prescriptions are sent to the pharmacy within two business days of completing the medical form, followed by discreet home delivery. Is Sprout Health's medication FDA-approved? The brand-name options (Wegovy® and Zepbound®) are FDA-approved. The compounded semaglutide and tirzepatide are not — Sprout Health states they have not been evaluated by the FDA for safety, effectiveness, or quality, and compounded drugs are neither brand-name nor generic. Check Sprout Health Pricing → Semaglutide from $149/mo · Tirzepatide from $199/mo · 100% online, US-licensed providers Disclaimer: This article is for informational and educational purposes only and is not medical advice. Compounded semaglutide and tirzepatide are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. A prescription is not guaranteed — eligibility, medication selection, and dosing are determined solely by a state-licensed provider. Pricing reflects published starting rates as of August 2026 and may change. Consult a qualified healthcare professional before starting any medication. PeptideStack page context: visitors can use the header navigation to reach the product catalog, blog, calculators, supplier pages, discount-code pages, contact page, legal policies, privacy policy, terms, and research disclaimer. The site is organized around research peptide education, supplier transparency, product comparison, vendor review content, discount-code tracking, and calculator tools for reconstitution or unit conversion research planning. PeptideStack separates research-use-only peptide information from FDA-approved medication and licensed telehealth pathways. Research peptide pages are informational and are not medical advice, prescription guidance, dosing instructions, treatment recommendations, or instructions for human consumption. Many pages include affiliate disclosures because PeptideStack may earn a commission when visitors click external supplier or telehealth links. That commission does not change the price paid by visitors and does not mean PeptideStack manufactures, sells, distributes, compounds, or ships peptides or medications. Supplier and product pages should be evaluated for third-party testing, batch-specific certificates of analysis, named laboratory verification, transparent pricing, realistic delivery expectations, payment security, refund policies, support quality, and consistent research-use-only labeling. Blog pages connect related guides, comparison articles, FDA approval status explainers, safety context, legality resources, product pages, vendor reviews, and calculator tools so visitors can keep researching without relying on a single supplier claim. Calculator pages are educational tools for laboratory planning and should be cross-checked against professional protocols, institutional requirements, and applicable laws. Legal and disclaimer pages explain the boundaries of PeptideStack content and the responsibility of visitors who evaluate third-party vendors. The rendered interface may add interactive details such as mobile navigation labels, product tabs, share buttons, related article cards, disclosure boxes, call-to-action buttons, vendor selectors, copy-code controls, email-code forms, footer navigation, and status labels. The static HTML fallback includes this context so the same page purpose is understandable before the JavaScript application finishes loading. Visitors should treat PeptideStack as a research and comparison starting point. Final supplier evaluation should include direct review of the external vendor website, current product availability, checkout terms, applicable laws, institutional requirements, and any third-party laboratory documentation available for the exact product or batch being considered. Footer resources repeat important sitewide context: PeptideStack is independent, affiliate-supported, research-focused, and not a pharmacy or manufacturer. Pages may include links to the iOS app, calculators, blog hubs, product hubs, supplier comparisons, support contact, and policy documents. This repeated context is intentionally available in the raw HTML for crawlers that inspect a page before executing the React bundle. Raw HTML also includes page summaries for mobile crawlers using JavaScript rendering, desktop crawlers comparing source to rendered output, accessibility tools, and no-script visitors. The fallback is replaced by the React app in normal browsers but keeps the source document aligned with the visible page topic. This fallback keeps source HTML and rendered HTML closer for crawl diagnostics and SEO audits across crawled pages, routes, reports, and recrawls.